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Introdução: Nas últimas décadas, tem-se observado um aumento da sobrevivência 
ao cancro da mama, sobretudo devido às tendências para o diagnóstico precoce e 
ao uso de tratamentos mais efetivos. No entanto, as sobreviventes de cancro da 
mama experienciam frequentemente efeitos tardios e a longo prazo do cancro e 
respetivos tratamentos, incluindo o maior risco de segundos cancros primários e 
outras doenças crónicas. A adoção de comportamentos mais saudáveis e Índice de 
Massa Corporal (IMC) adequado são essenciais para promover a saúde nas 
sobreviventes de cancro da mama, e o diagnóstico de cancro pode ser uma 
oportunidade para a melhoria destes comportamentos. 
Objetivos: Com este estudo pretendeu-se analisar as alterações nos 
comportamentos de saúde e no IMC após o diagnóstico de cancro da mama, 
descrevendo a possível influência das características sociodemográficas, clínicas e 
psicológicas, assim como dos níveis de literacia em saúde. 
Métodos: Foram incluídas neste estudo 428 participantes que fazem parte de uma 
coorte prospetiva de mulheres com diagnóstico recente de cancro da mama, 
admitidas na Clínica da Mama do Instituto Português de Oncologia do Porto, 
Portugal, durante o ano de 2012, e que participaram na avaliação de seguimento 
efetuada três anos após o diagnóstico. Nesta reavaliação recolheram-se dados 
sobre o consumo de tabaco, álcool, frutas e vegetais, prática de atividade física e 
IMC, relativamente ao período pré e pós-diagnóstico. Para quantificar as 
associações entre as características das sobreviventes e as mudanças em cada 
outcome, foram calculados os odds ratio ajustados (AOR) e respetivos intervalos de 
confiança (IC 95%), através de regressão logística. Esta análise foi estratificada 
tendo em conta a adesão às recomendações para prevenção do cancro no período 
anterior ao diagnóstico. 
Resultados: Após o diagnóstico, 54,1% das participantes pararam de praticar 
atividade física, 32,4% ficaram com excesso de peso ou obesidade, 6,1% reduziram 
o consumo de frutas e vegetais para menos que cinco porções por dia. Apenas uma 
mulher aumentou o seu consumo de álcool para mais que uma unidade por dia e 
nenhuma começou a fumar. Entre as sobreviventes que não cumpriam as 
recomendações antes do diagnóstico, 29,1% deixaram de fumar, 24,6% diminuíram 
o consumo de álcool para ≤1 unidade por dia, e 3,3% tinham IMC adequado. Menos 
de 10% das mulheres aumentou a sua atividade física e consumo de frutas e 
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vegetais. As mais velhas e com níveis mais elevados de escolaridade foram as que 
mais frequentemente pararam a prática de atividade física (AOR=4,71, IC 95%: 
1,17-18,99; AOR=11,53, IC 95%: 2,20-60,53, respetivamente). As mulheres mais 
velhas também iniciaram a prática de exercício físico com menor frequência 
(AOR=0,32, IC 95%: 0,14-0,75). 
Conclusão: As mulheres com diagnóstico de cancro da mama reportaram 
mudanças positivas nos seus comportamentos de saúde após o diagnóstico. No 
entanto, ainda existe uma ampla margem de intervenção, o que destaca a 
importância de desenvolver ações de promoção da saúde destinadas 
especificamente a esta população.  
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Background: In the last few decades, the trends towards earlier diagnosis and use 
of more effective treatments have contributed to an increased survival of breast 
cancer. Nevertheless, breast cancer survivors often experience late and long-term 
effects of disease and its treatments, including a higher risk of second primary 
cancers and other chronic diseases. Therefore, the adoption of healthier behaviours 
and adequate body mass index (BMI) are essential to promote overall health among 
breast cancer survivors, and cancer diagnosis may be an opportunity for its 
improvement. 
Objectives: We aimed to analyse changes in health behaviours and BMI among 
women after breast cancer diagnosis, depicting the potential influence of socio-
demographic characteristics, clinical and psychological features, and health literacy.  
Methods: In this study, we included 428 participants who were enrolled in a 
prospective cohort of women with newly diagnosed breast cancer, admitted to the 
Breast Clinic of the Portuguese Institute of Oncology of Porto, Portugal, during 2012, and 
who were evaluated three years after diagnosis. In this follow-up evaluation, data 
regarding smoking, alcohol consumption, physical activity, fruit and/or vegetables 
intake, and BMI, either pre- or post-diagnosis, were collected. To quantify 
associations between patients’ characteristics and changes in each outcome , 
adjusted odds ratio (AOR) and respective 95% confidence intervals (95% CI) were 
calculated using logistic regression. This analysis was stratified according to the 
participants’ adherence to cancer prevention recommendations before diagnosis.  
Results: After diagnosis, 54.1% of participants ceased the practice of physical 
activity, 32.4% became overweight/obese, and 6.1% reduced fruits and/vegetables 
intake to <5 portions/day. Only one women increased her alcohol consumption to 
more than one unit per day and none started to smoke. Among patients who did not 
meet recommendations pre-diagnosis, 29.1% stopped smoking, 24.6% diminished 
alcohol consumption to ≤ 1unit/day, and 3.3% had normal BMI. Less than 10% of 
women incremented their physical activity and fruit and/or vegetables intake. Older 
and higher educated participants were more likely to cease physical activity 
(AOR=4.71, 95% CI: 1.17-18.99; AOR=11.53, 95% CI: 2.20-60.53, respectively). 
Older women had also less odds to start this behaviour after diagnosis (AOR=0.32, 
95% CI: 0.14-0.75). 
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Conclusions: Although breast cancer patients reported some positive changes in 
health behaviours after diagnosis, there is still a large margin for improvement, which 
highlights the importance of outline health promotion interventions, specifically 
addressed to this population. 
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3.1 Trends in breast cancer incidence, survival and mortality 
 
3.1.1 Incidence 
 
3.1.1.1 Worldwide 
Breast cancer is the most common cancer among women worldwide and it is estimated 
that, in 2012, 1.7 million new cases were diagnosed, which represents 12% of all new 
cancer cases and 25% of all cancer in women (Figure 1) (1). In the same year, the 
highest age-standardized incidence rate (ASIR), world standard population (W), of 
breast cancer was in Western Europe (96.0/100 000), Northern America (91.6/100 000) 
and Northern Europe (89.4/100 000) and the lowest incidence in Middle Africa (26.8/100 
000), Eastern Asia (27.0/100 000) and South-Central Asia (28.2/100 000) (1). 
Globally, breast cancer incidence has been increasing over the years in historically 
lower-risk areas, such as Latin America, Africa and Asia, due to longer life expectancy, 
delayed childbearing and/or having fewer children, menopausal hormone use, the rising 
prevalence of obesity, as well as increased detection through (2). However, it has 
decreased in last decade in countries like United States of America (USA) (3, 4), Canada, 
Australia, United Kingdom (UK) and France (5) and it has been stable in the past years, 
mostly due to increase in breast cancer screening and lower use of postmenopausal 
combined hormone therapy (6-8).  
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Figure 1. Worldwide distribution of estimated age-standardized breast cancer incidence (per 100 
000) in 2012. 
 
Source: GLOBOCAN, 2012 (1). 
 
3.1.1.2 Europe 
In Europe, the estimated proportion of the total number of cancer cases was 28.8% due 
to breast cancer, which represents the most frequent cancer in women (9); the estimated 
ASIR, European standard population (E), of breast cancer among women was 92.8/100 
000 in 2012 (9). In that year, the ASIR (E) was higher in Belgium (147.5/100 000), 
followed by Denmark (142.8/100 000) and France (136.6/100 000). The lowest estimated 
ASIR (E) was observed in Bosnia Herzegovina (49.1/100 000), Moldova (52.9/100 000) 
and Ukraine (54.0/100 000) (Figure 2) (9). 
 
  
13 
 
 
 
Figure 2. Europe distribution of estimated age-standardized breast cancer incidence (per 100 
000) in 2012. 
 
Source: EUCAN, 2012 (9). 
 
3.1.1.3 Portugal 
In Portugal, the most recent data revealed an ASIR (E) of 93.2/100 000 in women in 
2010 (10). Specifically in Northern Portugal, the estimated ASIR (E) was 93.9/100 000 
(11), and it is expected that this number continues to increase in the next years (Figure 
3) (12). 
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Figure 3. Incidence trends and predictions for North Portugal. 
 
Source: North Region Cancer Registry (RORENO), 2014 (12). 
 
3.1.2 Survival 
 
3.1.2.1 Worldwide 
The increasing number of new cases of breast cancer observed in the last few years, 
along with the intense activities for early detection and the access to more effective 
treatments, have contributed to the increasing number of breast cancer survivors (13). 
Worldwide, in 2012, there were an estimated 6.2 million breast survivors alive five years 
after diagnosis (1), with the highest proportion from Northern America and the lowest 
from African and Asian countries. 
According to the data available from the CONCORD-2 Study, the age-standardized five-
year net survival of breast cancer was 80% or higher in 34 countries all over the world, 
including Cyprus (90.6%), USA (88.6%) and Brazil (87.4%), being lower than 65% in 
South Africa (53.4%), Mongolia (56.5%) and India (60.4%). Between 1995-1999 and 
2005-2009, breast cancer survival increased in countries like Central and South America, 
particularly in Brazil (from 78% to 87%), Colombia (from 66% to 76%), and Ecuador (from 
69% to 83%). Likewise, in North America and Oceania breast cancer survival was high 
with range between 84-89% and with stable or slightly improving in survival in the period 
of 2005-2009. In Europe, survival increased as well, although it was lower than North 
America and Oceania, and had wider geographic range (13). Moreover, in Algeria 
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survival also increased (from 17% to 60%) but this trend is less reliable and survival 
trends of several African countries were not available (Figure 4) (13). 
 
Figure 4. Trends in age-standardized 5-year net survival for women diagnosed with breast 
cancer during 1995–99, 2000–04, and 2005–09, by continent or region and country. 
 
Source: Allemani et al., 2015 (13). 
 
Differences in tumour stage at diagnosis may be one important factor for the observed 
geographical differences. In fact, the five-year survival is lower among women with 
cancer in a more advanced stage, namely 99% for localized disease, 84% for regional 
disease and 24% for distant-stage disease (5, 14-16). In the UK, USA, Canada, Denmark 
and China more than three-quarters of breast cancers are diagnosed at an early stage 
(I or II) (5). In contrast, in several developing countries (e.g. Nigeria, Libya and Malaysia), 
the breast cancer is diagnosed at a later stage (III or IV) (5). Some explanations for late-
stage diagnosis include lack of awareness, limited access to adequate detection and 
diagnostic services, social barriers (such as reluctance or refusal to have one’s breast 
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examined by a male doctor), stigma linked to breast cancer and its treatment, and also 
the belief that cancer is fatal and cannot be changed through individual action (5). 
In addition to stage, tumour grade, hormone receptor status and human epidermal 
growth factor receptor 2 status influence survival (16). Moreover, the tumour size at 
diagnosis is predictive of the survival; in other words, larger tumour size is associated 
with decrease survival (14, 16). Likewise, 5-year relative survival rate is lower among 
women with less than age 40 at the diagnosis (85%), compared with those at 40 years 
old or older (90%), maybe because the higher aggressiveness of the tumour and/or lower 
responsiveness to treatment (14, 16). Data from the USA also revealed that survival is 
lower for black than white women at every stage of diagnosis: for all stages combined, 
the 5-year relative survival rate is 90% for white women and 79% for black women (14, 
16). The reasons for these differences are complex, but can be due to socioeconomic 
factors, less access and utilization of quality medical care and biological differences in 
cancers (16). 
 
3.1.2.2 Europe 
In Europe, and according to the EUROCARE study, in the last few years, it was observed 
an increment in breast cancer survival: from 1999-2001 to 2005-2007 it increased from 
78.4% to 82.4%. Across Europe, the mean age-standardized five-year relative survival 
was 81.8% for breast cancer in women, and most of the countries were close to the 
European mean (Figure 5) (17). 
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Figure 5. Age-standardized 5-year relative survival for adult breast cancer women followed-up 
in 1999–2001, 2002–04 and 2005–07. 
 
Source: De Angelis et al., 2014 (17). 
 
The estimated 5-year age-standardised relative survival was highest in Iceland (87.2%), 
followed by France (86.1%) and by Sweden (86.0%); the lowest were observed in 
Lithuania (66.7%), Latvia (69.3%) and Poland (71.6%) (17). 
Considering the specific-age, breast cancer survival was greater in women between 45 
and 54 years and it decrease with age. In women aged 75 years and older, survival was 
particularly low in the UK and Ireland, accounting for most of the survival difference 
between these countries and the European mean (17). 
 
3.1.2.3 Portugal 
According to the EUROCARE study, in Portugal, the 5-year age-standardized relative 
survival for patients with breast cancer, diagnosed during 2000-2007, was 83.3%, 
although in this estimate it was only included part of national population covered by 
cancer registration (17). 
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In the Northern region of the country, and taking into account data from the North Region 
Cancer Registry (RORENO), between 2007 and 2008, the observed 5-year survival rate 
was 83.6% and the net survival rate was 89.4% (18). In table 1 is presented the evolution 
of breast cancer survival and it is notable the progress in survival all over the years (18, 
19). 
 
Table 1. Evolution in breast cancer survival in women, in the first, third and five-year, between 
2005 and 2008, in the North Region. 
Breast cancer survival 
  1 year 3 years 5 years 
2005-2006 
SO 
(95% CI) 
95.5 
(94.7-96.2) 
87.1 
(85.8-88.2) 
80.6 
(79.1-82.0) 
SN 
(95% CI) 
96.8 
(96.0-97.5) 
91.0 
(89.6-92.2) 
86.9 
(85.3-88.4) 
2007-2008 
SO 
(95% CI) 
96.2 
(95.5-96.8) 
89.6 
(88.5-90.5) 
83.4 
(82.1-84.6) 
SN 
(95% CI) 
97.4 
(96.8-98.1) 
92.9 
(91.8-94.0) 
89.1 
(87.7-90.5) 
CI: confidence interval; SO: observed survival; SN: net survival. 
Source: RORENO, 2013 (19) and 2014 (18). 
 
Moreover, it was also observable an inverse relationship between net survival and age, 
i.e., the older women have lower survival, except the women aged 45-54, that in the first-
year have the highest net survival rate (Figure 6) (18). 
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Figure 6. Breast cancer net survival rate in women of North Region, according to age, in 2007-
2008. 
 
Source: RORENO, 2014 (18). 
 
3.1.3 Mortality 
 
3.1.3.1 Worldwide 
Overall, breast cancer was the fifth cause of death (521 800 deaths, 6.4%) in 2012, and 
it was the most frequent cause of cancer death in women in less developed countries 
(324 300 deaths, which represents 14.3% of total deaths), and it was the second cause 
of cancer death in more developed countries (197 500 deaths, which represents 15.4% 
of the total), after lung cancer (1). The range in age-standardized mortality rates (ASMR), 
between world regions is less than that for incidence because of the more favourable 
survival of breast cancer in developed countries, with rates ranging from 6.0/100 000 in 
Eastern Asia to 20.0/100 000 in Western Africa. The estimated ASMR (W) was highest 
in Western Africa (20.1/100 000), followed by Melanesia (19.8/100 000) and Northern 
Africa (17.4/100 000). The lowest estimated ASMR (W) was visible in Eastern Asia 
(6.2/100 000), Central America (9.5/100 000) and Micronesia/Polynesia (13.1/100 000) 
(Figure 7) (1).  
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Figure 7. Worldwide distribution of estimated age-standardized breast cancer mortality (per 100 
000) in 2012. 
 
Source: GLOBOCAN, 2012 (1). 
 
Although for many years there was a relatively slow increase in breast cancer death rates 
(0.4% from 1975 to 1990), from 1990 to 2010 mortality decreased by a mean of 34% in 
the USA, Canada and many European countries (20). This decline was more 
pronounced among women younger than 50 years, when compared with those with 50 
or more years of age (3.1% versus 1.9% per year). These trends are associated with 
improvements in the proportion of cases with early detection and breast cancer treatment 
(21), although the respective contributions of each may vary depending on the level of 
participation in regular screening and availability of state-of-the-art treatment (22). 
Nonetheless, in some less developed regions, breast cancer is the leading cause of 
cancer death among women and mortality rates are continuously increasing, due to an 
increasing on incidence and, in some cases, limited access to treatment (1). 
 
3.1.3.2 Europe 
Among European countries, in 2012, breast cancer was the leading cause of death in 
women (16.8% of the total number of deaths). The estimated ASMR (E), in the same 
period, was 23.2/100 000, being particularly higher in Macedonia (36.3/100 000), Serbia 
(31.5/100 000) and Belgium (29.5/100 000). The lowest estimated ASMR (E) was 
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observed in Estonia (15.1/100 000), Spain (16.7/100 000) and Bosnia Herzegovina 
(16.9/100 000) (Figure 8) (9). 
 
Figure 8. Europe distribution of estimated age-standardized breast cancer mortality (per 100 
000) in 2012. 
 
Source: EUCAN, 2012 (9). 
 
Between 1980 and 2010, there was a stable or slightly increasing in ASMR (E) in the first 
half of the period, and then there was a visible decline, mostly in high-income countries 
from Western and Northern Europe (23). In the same period, there were countries, 
especially from Eastern and Northern Europe with the lowest median ASMR (E) at the 
1980’s that increased their ASMR (E) during the first period and decreased mainly after 
1999. The decline in ASMR (E) in this period can be explained by an increase in 
screening programs and a better access to treatments, which were initiated before 1995 
in some countries of Northern, Southern, Western and Eastern Europe (23). 
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3.1.3.3 Portugal 
In Portugal, breast cancer ASMR (E) declined two percent per year between 1992 and 
2002 in several regions (Figure 9) and this decline was more marked in the districts that 
had larger incidence rates, like Lisbon, Viseu and Faro, respectively (24). Most recent 
data revealed that, in 2014, the ASMR (E) was 17.9 deaths per 100 000 (10). 
 
Figure 9: Evolution of breast cancer mortality rate (age-standardized, European population) in 
women aged 35-74 years old, between 1955 and 2002. 
 
Source: Bastos et al., 2007 (24). 
 
The ASMR (E) in Northern Portugal was 15.5/100 000 in all ages, and 9.3/100 000 in 
women aged less than 65 years old, in 2014 (10).  
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3.2 Lifestyles among breast cancer survivors 
In the past decades there has been an increasing number of breast cancer survivors, 
due to improvements towards early detection, curative therapies, increment of life 
expectancy and ageing (25). Nevertheless, breast cancer survivors have an 
increased risk of recurrence, late effects of treatments, mortality due to non-cancer 
causes, and they are more likely to develop second primary cancers and a variety 
of symptoms, that can adversely affect quality of life (26-29). Furthermore, breast 
cancer survivors are at increased risk for chronic diseases, such as cardiovascular 
disease, diabetes, and osteoporosis (26, 30). 
Despite these negative outcomes may be the result of disease and its treatments,  
lifestyles also play a role (31, 32). Although a cancer diagnosis has been referred as 
a teachable moment, where survivors are motivated to make lifestyle changes to 
improve health outcomes (33, 34), recent studies found that few cancer survivors are 
actually meeting recommendations (35-39). 
These findings emphasize the important role of health promotion actions in 
enhancing the adherence to healthier behaviours and BMI, among breast cancer 
survivors. 
 
3.2.1 Smoking 
Previous studies have shown that smoking is associated with poor prognosis among 
breast cancer survivors (40, 41). For instance, compared with never smokers, current 
smokers have greater risk of breast cancer specific mortality (40-44), recurrence (40), 
more and larger lymph node metastases (45) and higher risk of all-cause mortality (40, 
43, 46). Some studies also suggested that smoking may reduce the                                                                                                                                                                                                                                                
effectiveness of cancer therapies (47), and has been associated with more surgical 
complications (48), as well as with an increased risk of developing a second primary 
cancer (49). Additionally, smoking habits may be associated with lower levels of quality 
of life (50). In fact, compared with non-smokers, persistent smokers had higher likelihood 
of reporting poor physical functioning, mental health, and role emotional (50). Moreover, 
those who persist smoking report higher levels of usual pain, compared to non-smokers 
or former smokers, especially those who are younger, have lower perceived health status 
and some cancer symptoms (51). 
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Considering these facts, smoking cessation is one of the recommended strategies for 
health promotion among cancer survivors (33). However, between 10% and 23% 
continue to smoke after diagnosis (35-37, 39, 52-57). Results from several studies also 
reveal that cancer survivors quit smoking after their cancer diagnosis, in a 
percentage between 34% and 46% (39, 52, 55, 58). This lack of engagement in 
health behaviours has been explained by several factors, including the distress 
related with cancer diagnosis (59). 
Realizing that recommendations from healthcare providers have a significant impact on 
patient behaviour (60), health professionals must take into account that a breast cancer 
diagnosis may be an opportunity to promote changes in risk behaviours, namely the 
smoking cessation (41, 50) and, consequently, improve other health outcomes (41, 58). 
 
3.2.2 Alcohol 
The association between alcohol consumption and prognosis after breast cancer 
diagnosis has been inconsistent (61), due to some evidence that indicates that alcohol 
consumption has positive but also negative health effects (62). By one hand, prior studies 
suggest that moderate alcohol intake was not associated with the risk of recurrence (63, 
64) and non-breast cancer mortality (64, 65), and is associated with a small reduction in 
breast cancer–specific mortality for women with ER-negative disease (61). Also, in the 
Women's Healthy Eating and Living (WHEL) study, moderate/heavy alcohol intake 
(>300g/month) was protective against all-cause mortality in a proportional hazards model 
adjusted for obesity (63). On the other hand, compared with non-drinkers, high levels of 
alcohol intake seems to increase breast cancer mortality and recurrence (with an intake 
of 6g/day) (66). The risk of recurrence due to drinking was greater in overweight women, 
but was not associated with all-cause death, suggesting a cardio-protective effect (66). 
Additionally, after diagnosis, alcohol intake was not associated with disease-specific 
survival, compared with non-drinkers, and results did not vary by beverage type; those 
who consumed moderate levels of alcohol, either before or after diagnosis, experienced 
better cardiovascular and overall survival than non-drinkers (67). 
According to the latest guidelines, the recommendations for alcohol use are to limit its 
intake to no more than two drinks per day for men and one drink per day for women, 
which is also suggested for cancer survivors (68). However, reports of excessive drinking 
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among cancer survivors (including breast) ranged from 4.7% to 41.0% (35-37, 54, 56), 
although different criteria for excessive drinking were used across studies.  
Given the incongruent results regarding alcohol consumption, following a breast cancer 
diagnosis, further confirmation is needed in other prospective studies (64). In addition, 
healthcare providers must consider some factors when making recommendations, such 
as cancer type and stage of disease, treatment, treatment-related side effects (69), risk 
factors for recurrence or new primary cancers and comorbid conditions (62, 64). 
 
3.2.3 Physical activity 
Physical activity has been associated with several positive health-related effects among 
breast cancer survivors. In fact, data from a meta-analysis found that post-diagnosis 
physical activity decreased breast cancer deaths, all-causes mortality, disease 
recurrence and poorer breast cancer prognosis (70). Post-diagnosis physical activity 
also reduced the risk of mortality among women with BMI ≥25 kg/m2 and reduced breast 
cancer deaths and all-causes mortality among patients with oestrogen receptor positive 
tumour (70). 
Furthermore, physical activity has been shown to enhance quality of life among breast 
cancer survivors (71-73). Particularly, physical activity improves cardiovascular fitness, 
muscle strength, body composition, social functioning, self-esteem and physical, 
functional and emotional components of life’s quality and has been associated with lower 
levels of fatigue, anxiety and depression in breast cancer survivors (71, 74). Likewise, 
physical activity is associated with improvements in other adverse effects of cancer, like 
lymphedema by ameliorating symptoms and its severity for those in whom the condition 
was pre-existing (75). 
Taking into account recommendations from the World Cancer Research Fund for cancer 
prevention (76), general population and cancer survivors should be physically active for 
at least 30 minutes every day. However, only 20-30% of breast cancer survivors were 
active after they recover from treatments, and in USA it estimated that only 37% of breast 
cancer survivors are meeting American College of Sports Medicine guidelines for 
physical activity, that advocates that adults aged 18-64 years should practice at least 
150 minutes per week of moderate intensity or 75 minutes per week of vigorous intensity 
aerobic physical activity or an equivalent combination of moderate and vigorous intensity 
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aerobic physical activity (62). The training sessions should be done in episodes of at 
least 10 minutes for session and spread throughout the week. Likewise, adults should 
perform muscle-strengthening activities involving all major muscle groups at least two 
days per week. Individuals aged 65 years or older should follow these recommendations 
as possible with their chronic conditions. 
Accounting on these facts, regular physical activity is an effective intervention to improve 
quality of life in breast cancer patients and survivors (71), and together with a healthy 
diet, it promotes general health and well-being over the long-term (77) and decreases 
comorbid conditions, like cardiovascular disease and diabetes (78, 79). 
 
3.2.4 Diet 
Healthier dietary habits are a source of overall health and it is related to specific cancer 
outcomes (80). However, particularly for breast cancer, evidence from previous studies 
is mixed. During the past decade, the effect of diet after breast cancer has become 
relevant in research, focused on single macronutrients and specific nutrients (75), such 
as fat intake (76), and the study of overall diet quality (81). Recent evidence in diet 
evaluation takes into account the complexity of diet and the potentially synergistic or 
antagonistic effects of all individual dietary components (77). However, there are few 
studies that examine benefits for survival in association with overall dietary patterns (82). 
The impact of diet after breast cancer diagnosis has been found in several studies. 
Overall, results suggests that women who consume better quality diet (high intakes of 
vegetables, fruits, vegetable oil, sauces/condiments, and soups/bouillons) have lower 
risk of death from any cause and lower risk of death from non-breast-cancer causes, 
compared with an unhealthy dietary pattern (high intakes of red meat, processed meat, 
and deep-frying fat) (83). Also, high-fat dairy intake was associated with different health-
related outcomes: women who consumed larger amounts of high-fat dairy had higher 
breast cancer mortality (84), breast cancer recurrence (84) and higher non–breast 
cancer mortality (85); trans-fat intake was also linked with a 45% and 78% increased risk 
of all-cause mortality (86). 
The consumption of five or more daily servings of fruit and vegetables is related with 
better survival (87) and lower risk of mortality (88), with a protective effect in recurrence 
(89, 90). Moreover, evidence suggests that a low-fat and high-fibre diet might be 
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protective against cancer recurrence and progression (91), as well, the omega-3 fat 
intake is linked with an inverse association with all-cause mortality (86). Likewise, in a 
study who examined the association between healthy eating practices and quality of life 
found that breast cancer survivors with healthy eating practices had better global quality 
of life, social, emotional, cognitive and role functions (92). 
Dietary guidelines from World Cancer Research Fund recommend cancer survivors to 
consume at least 5 portions of fruit and vegetables each day (76). Studies assessing 
the prevalence of fruit and vegetables consumption found that only 18 to 47% of 
cancer survivors (including breast) are meeting recommendations (38, 39, 56, 57), 
even if after diagnosis the consumption tends to increase. 
Some studies have been testing the effect of diet modification in breast cancer survivors 
and they have shown conflicting results (93, 94). The WHEL study tested the effect of a 
diet very high in vegetables, fruit, and fibre and low in fat on cancer outcomes in pre and 
postmenopausal breast cancer survivors (93). At 6 years, the intervention group had 
increased to an average of 9.2 servings per day, whereas the control group averaged 
6.2 servings per day. Recurrence-free survival did not differ between the two study arms 
(93). Nevertheless, in the Women's Intervention Nutrition Study, that evaluated a low-
fat diet in postmenopausal women with early-stage breast cancer (94), although on 
average the women in the intervention arm only decreased fat intake to 20% of energy 
at year one, after five years of follow-up, results showed that a diet low in fat 
demonstrated a significant decrease in breast cancer survival and new breast cancer 
events, compared with those in the control group (94). 
In summary, diet is a potentially modified factor and health professionals should 
emphasize vegetables and fruits intake, parallel to regular physical activity and a healthy 
weight (62). Some trials demonstrate that a sustainable dietary modification, based on 
Mediterranean and macrobiotic dietary principles, can reduce body weight, metabolic 
syndrome and the bioavailability of sex hormones and growth factors (95). These results 
suggest that dietary changes should be recommended both for breast cancer prevention 
and treatment (95). 
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3.2.5 Body mass index 
Many cancer survivors are overweight or obese at the time of diagnosis and it is known 
that overweight is associated with an increase in risk of developing many cancers (62), 
and also affects survival for postmenopausal women with breast cancer (15). 
The impact of obesity after breast cancer diagnosis was found in several studies (96-
105), mostly related to breast cancer mortality or recurrence, based on BMI, but not all 
studies had statistical significant results. Overall, evidence shows an increase in 
recurrence rate (106), although few studies also present rate ratios below one (107) and 
null results (97, 99). Specifically, findings on the effect of BMI among pre or post-
menopausal obese women, showed a greater rate in mortality from breast cancer in 
obese women, compared to normal weight women (104, 108). Furthermore, despite of 
most studies assess mortality rates in obese women (BMI≥30 kg/m2) with breast cancer, 
when very obese women are included, this group presents the highest mortality rate 
(108); however, other studies found similar results among obese and very obese women, 
both having higher mortality rates than normal weight women (109, 110). 
According to the “The Nutrition and Physical Activity Guidelines for Cancer Survivors” 
from American Cancer Society and recommendations from the World Cancer Research 
Fund, individuals who are overweight or obese should be encouraged and supported in 
their efforts to reduce their weight (62, 76). Despite these recommendations, results from 
the After Breast Cancer Pooling Project showed a prevalence of overweight and obesity 
of 32.6% and 17.9%, respectively (111) and a considerable part of women modify body 
weight after diagnosis.  
A review, which investigated the frequency, magnitude and pattern of weight gain among 
breast cancer survivors, revealed that 50–96% of women experience weight gain during 
treatment and women who maintains a stable weight during treatments also report 
growing weight gain in the months and years after diagnosis (112).The average weight 
gain ranged from 2.5-6.2kg, although higher gain was also common (113). Factors 
associated with weight gain were women receiving adjuvant chemotherapy (112, 114, 
115), principally those with long-duration treatments and premenopausal women (112), 
higher disease stage, younger age, being postmenopausal, and those who decreased 
their physical activity from diagnosis to within 3 years after diagnosis (113). 
Weight change after a breast cancer diagnosis has been associated with lower survival 
(98, 116) and increased breast cancer mortality (101, 117), cardiovascular disease 
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mortality and all-cause mortality (101). Weight change is also associated with health-
related quality of life. In a cohort study with breast cancer survivors, compared to women 
with BMI <25 kg/m2, women with BMI ≥30 kg/m2 had increased arm symptoms, urinary 
incontinence, tendency to nap, and poorer physical functioning (118). Moreover, women 
with ≥5% weight gain had lower scores in physical functioning, role-physical and vitality, 
and participants with weight loss ≥5% had lower chest wall and arm symptom scores 
(118). 
Overall, weight losses of 5% to 10% have significant health benefits, even if the ideal 
weight is not achieved (119). Among breast cancer survivors who are overweight or 
obese, the loss that comes from caloric restriction and intentional exercise enhances the 
quality of life and physical functioning. In addition, losing weight may reduce the risk of 
postmenopausal breast cancer (120, 121) and possibly other cancers (97, 122-124) in 
women without cancer.  
Behavioural interventions can lead to weight loss in overweight and obese breast cancer 
survivors (125). This loss is beneficial to reduce the risk of recurrence among post-
menopausal breast cancer survivors, especially those with oestrogen receptor ER 
negative tumours (126). On the other hand, it is known that weight management it is 
crucial for rehabilitation and recovery from treatments (obesity is related to increased 
operating and recovery times, higher infection rates, and poorer healing), to prevent 
comorbid conditions, such us cardiovascular disease and diabetes (127) and 
lymphedema (127, 128), fatigue, hot flashes (127, 129), functional decline and poorer 
health and overall quality of life (118, 127). Also, weight loss in the Exercise and Nutrition 
to Enhance Recovery and Good Health for You study lead survivors to improve their 
physical activity and blood pressure (125). 
These findings are important to healthcare providers to enhance weight management, 
for instance through the promotion of healthy diet and physical activity, at all phases of 
the cancer care, in order to prevent sequelae and to improve general health (112, 127) 
and survival (101) and weight control strategies should be personalized to the medical 
history of survivors (116). 
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3.3 Factors associated with health behaviours and body mass index after 
breast cancer diagnosis 
Changes in health behaviours and body mass index after a breast cancer diagnosis are 
influenced by a heterogeneous and complex variety of intrinsic and extrinsic factors. 
Nevertheless, the effect of each explanatory variable is inconsistent when specific health 
behaviour and anthropometric characteristics are analysed. 
 
3.3.1 Socio-demographic characteristics 
Regarding socio-demographic characteristics, older age has been associated with 
improvements in health behaviours among cancer survivors. In fact, when compared 
with younger patients, older adult cancer (including breast) survivors were significantly 
more likely to quit smoking (52); to improve their dietary behaviours, by decreasing their 
intake of fat and amount of takeaway food, and increase fibre and fruits/vegetables intake 
(130); to maintain their exercise levels after cancer diagnosis (52). However, other 
studies reported that older patients are frequently more physically inactive after 
treatments (33, 131, 132) and have less improvements in diet (132). 
Subjects with higher education levels are also more likely to make positive changes in 
lifestyles (33), namely regarding dietary habits (33, 133) and physical activity (33, 131, 
133, 134), although in another study they did not found changes in health behaviours 
depending on the education levels (130). 
Employment status may be influenced by cancer diagnosis and treatment. A meta-
analysis demonstrated that cancer survivors are 1.4 times more likely to be unemployed 
than healthy controls (135), and this risk was also identified for survivors of breast cancer 
(136). Those who returned to work were less likely to be young and out of active 
treatment (137), but evidence on the age effects on the return to work is conflicting (136-
138). Yet, compared to young-adults, middle-aged adults are more often 
unemployed/homemaker or retired (139). Reasons on the basis of that are physical 
limitations, cancer-related symptoms, stage, time since diagnosis and socioeconomic 
factors (137-139). Furthermore, compared to middle-aged adults, young adults have 
higher functioning level at work, doing daily activities or pursuing own hobbies. In relation 
to lifestyles, a study of Humpel et al. (130) found that more employed individuals 
increased the intake of fibre compared to those not employed, while in another study no 
association was observed (132). 
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In addition, adult cancer survivors living in rural areas were significantly more likely to 
quit smoking after cancer diagnosis compared to those living in urban areas (52), and 
women who engaged in exercise practice were mostly married or living with a partner 
(140), although in other study there were no significant associations between physical 
activity and marital status (134). 
 
3.3.2 Medical conditions 
Clinical features may also influence the adoption of healthier lifestyles. For instance, it 
has been described that advanced stages of breast cancer are associated with lower 
interest in health issues (141) and diminished levels of physical activity (131, 134). 
Additionally, a review assessing cancer-related variables demonstrated that a higher 
stage of tumour, and more invasive or numerous treatment modalities, were related to 
greater improvement in diet, exercise, and smoking behaviour (132). 
Time since diagnosis also plays a role in predicting health behaviours after diagnosis. 
Typically, the longer the time since diagnosis, the more positive the health behaviour 
changes (132). Cancer survivors who had completed treatment for more than one year 
are significantly more likely to make positive lifestyles changes (52, 133, 140), namely 
for maintaining their exercise levels after cancer diagnosis (52), although in another 
studies they did not find changes in health behaviours depending on the time since 
diagnosis (130, 134). 
Patients who received radiation therapy report higher levels of physical activity, 
compared to those who receive chemotherapy or a combination of radiation and 
chemotherapy (134). Moreover, patients receiving three or more treatments are more 
likely to make dietary changes or start new physical activity, compared with patients 
receiving only one medical treatment (133). In addition, patients who quit smoking pre-
surgery had better long-term abstinence rates than those who quit after surgery (140) 
and patients with comorbidities and being current smokers were more likely be physically 
inactive after treatments (131). 
 
3.3.3 Psychological features 
With regards to psychological features, patients with depressive symptoms reported 
lower levels of physical activity and those that were physically inactive were also more 
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likely to have lower adherence to dietary recommendations when compared to active 
patients (134). Additionally, other psychosocial characteristics, including social support 
and self-efficacy are predictors of fruit and vegetables intake (142). 
In an inverse way, it has been hypothesized that distress, which includes anxiety and 
depression, may also be related with healthier behaviours, based on the notion that 
distress, especially fear, may give rise to motivation to change, making adaptive health 
behaviour changes, and may be a way of coping with distress (132). Pinto et al. found 
that higher baseline depression was related to subsequent increased vigorous exercise 
(143). Likewise, Maunsell et al. (32) observed that higher levels of depression were 
associated with more positive dietary changes in a sample of breast cancer patients in 
the first year after diagnosis; subsequent declines in levels of depression over the first 
year were also related to more positive dietary changes (132). 
 
3.3.4 Health literacy 
Health literacy has been a relevant and significant topic recognized globally, since it is 
considered a key factor in health promotion and it contributes to a healthier society (144). 
In fact, health literacy is associated with the ability to understand, interpret and analyse 
health information (such as diagnosis and treatments regimens) (144), the access to 
healthcare and preventive services, and possessing the ability to act on health 
information to improve overall health (145). Therefore, limited health literacy has been 
linked with poor health outcomes; for instance, people with limited health literacy are 
more likely to die from a chronic disease (144), such as cardiovascular disease (146), 
they have an increased risk of all-cause mortality (146), and they have poorer overall 
health (147), compared with those with higher health literacy levels. Moreover, the ones 
with limited health literacy have lack of ability to self-manage health effectively, access 
health services, understand available and relevant information and make informed 
health-related decisions and planning and adjusting lifestyle (148). 
Limited health literacy is related with numerous modifiable risk factors for non-
communicable diseases, including lack of physical activity, poor dietary habits, smoking 
and alcohol use (148). Results from European Health Literacy Survey which included 
health-related behaviours (smoking, alcohol, body mass index and physical exercise) 
showed associations, although different according to countries involved, but physical 
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activity was consistent and strongly associated with health literacy: the higher the health 
literacy, the higher the frequency of physical exercise (148). 
Moreover, individuals with low health literacy were more likely to avoid physician visits, 
had lower knowledge about most common cancer screening tests and are less likely to 
look for health information from sources other than physicians (149). 
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4. Objectives 
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The growing number of breast cancer survivors worldwide, and their higher risk of 
comorbidities, highlights the relevance of studying multiple lifestyles risk factors, such as 
smoking status, alcohol consumption, physical activity, dietary patterns and BMI. 
Therefore, local specific data characterizing modifiable health behaviours within breast 
cancer survivors is crucial to implement lifestyles interventions in this population. 
Thus, the main objective of this project is to analyse changes in health behaviours and 
BMI after breast cancer diagnosis, depicting the potential influence of socio-demographic 
characteristics, clinical and psychological features, and health literacy.  
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Abstract 
Background: The adoption of healthier behaviours and body mass index (BMI) is 
essential to promote overall health among breast cancer survivors. The diagnosis of a 
cancer may contribute for its improvement among survivors. 
Objectives: To analyse changes in health behaviours and BMI after breast cancer, 
depicting the potential influence of socio-demographic characteristics, clinical and 
psychological features, and health literacy. 
Methods: We included 428 breast cancer patients prospectively followed for three years 
after diagnosis. Data regarding smoking, alcohol consumption, physical activity, fruit 
and/or vegetables intake, and BMI, either pre- or post-diagnosis, were collected at the 
end of follow-up. To quantify associations between patients’ characteristics and changes 
in each outcome, adjusted odds ratio (AOR) and respective 95% confidence intervals 
(95% CI) were calculated using logistic regression. 
Results: After diagnosis, 54.1% ceased the practice of physical activity, 32.4% became 
overweight/obese, and 6.1% reduced fruits and/vegetables intake to <5portions/day; 
there were virtually no changes towards alcohol consumption to >1unit/day or smoking. 
Among patients who did not meet recommendations before diagnosis, 29.1% stopped 
smoking, 24.6% diminished alcohol consumption to ≤1unit/day, and 3.3% had normal 
BMI. Older and more educated participants were more likely to cease physical activity 
(AOR=4.71, 95% CI: 1.17-18.99; AOR=11.53, 95% CI: 2.20-60.53, respectively). Older 
women had also lower odds to start this behaviour after diagnosis (AOR=0.32, 95% CI: 
0.14-0.75). 
Conclusions: Breast cancer patients showed some positive changes in their health 
behaviours after diagnosis; however, there is a large margin for improvement, which 
highlights the urgent demand for health promotion interventions in this context. 
 
Keywords 
Breast cancer; Cancer survivorship; Health behaviours; Body Mass Index.  
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Introduction 
In the last few decades, the trends towards earlier diagnosis of breast cancer and use of 
more effective treatments have been contributed to an increased incidence and survival, 
and lower mortality rates (1-4). Consequently, in 2012, there were more than six million 
women with breast cancer alive at least five years after diagnosis (1), and it is expected 
that this prevalence continues to increase in the next years. Breast cancer survivors often 
experience late and long-term effects of disease and its treatments, including a higher 
risk of second primary cancers and other comorbidities, such as cardiovascular disease, 
osteoporosis, diabetes, sleep disturbances and depression (5-7). 
The adoption of healthier behaviours, such as avoidance of smoking consumption, 
reduction of alcohol drinking, higher fruit and vegetables intake and physical activity, 
have been associated with decreased risk of cancer incidence (including breast cancer) 
(8, 9) and mortality (10-12), as well as increased survival of breast cancer (13-15), lower 
rates of recurrence (14, 16), and second primary cancers (17). These behaviours are 
also linked with lower prevalence of cancer and treatment-related symptoms (18, 19), 
and health-related quality of life after diagnosis (20, 21). Additionally, normal weight 
women also have decreased risk of breast cancer mortality (22) and recurrence (23), 
and other physical symptoms after breast cancer diagnosis, including increased arm 
symptoms, urinary incontinence, tendency to nap, and poorer physical functioning (24). 
This highlights the importance of health promotion efforts after a breast cancer diagnosis, 
taking advantage of the fact that women may be more motivated to improve their own 
health and to adopt a healthier lifestyle after this life event (25). 
Local specific data characterizing modifiable health behaviours and anthropometric 
features among breast cancer survivors is essential to implement lifestyles interventions 
in particular settings. Therefore, we aim to analyse changes in health behaviours and 
body mass index after breast cancer diagnosis, depicting the potential influence of socio-
demographic characteristics, cancer stage, anxiety and depression, and health literacy.  
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Methods 
Study design and participants 
The present analysis is based on a prospective cohort study of newly diagnosed breast 
cancer women. The study protocol has been previously described in detail elsewhere 
(26). Briefly, patients proposed for surgery were consecutively recruited in 2012, among 
those admitted to the Breast Clinic of the Portuguese Institute of Oncology of Porto, 
Portugal. Women that had received any treatment for breast cancer before, those 
previously treated with chemotherapy and/or radiotherapy in the chest and/or axillary 
areas for other primary cancers, and those considered less likely to be able to cooperate 
due to cognitive impairment [score lower than 17, or lower than 16 for women over 65 
years, in the Montreal Cognitive Assessment (MoCA) (27, 28), were excluded. Overall, 
506 patients with incident breast cancer were enrolled in this cohort. 
Between January 2015 and January 2016, a three-year follow-up evaluation was 
conducted. Thirty one women were lost to follow-up: 11 patients died, 10 abandoned the 
study, six could not be contacted, two were transferred to another hospital and two were 
considered unable to cooperate by the neurologist. Therefore, a total of 475 (93.9%) 
completed this evaluation. Additionally, for the purposes of the present analysis, we also 
excluded women with cancer stage IV at baseline (n=3), patients with cancer recurrence 
(n=12) or a diagnosis of another cancer (n=32), remaining 428 breast cancer patients. 
The study was approved by the Ethics Committee of Portuguese Institute of Oncology of 
Porto (Ref. CES 406/011 and CES 99/014) and by the Portuguese Data Protection 
Authority. All participants provided written informed consent. 
 
Data collection 
Data regarding health behaviours, either pre- or post-diagnosis, namely smoking status, 
alcohol consumption, physical activity (practice of sports or other physical activity), and 
fruit and/or vegetables intake (frequencies of consumption of fruits, vegetables side dish 
and soup) were collected through face-to-face interview at the three-year follow-up 
evaluation. Body weight at diagnosis and height was retrieved from the clinical records, 
and body weight three years after diagnosis was measured to the nearest 0.1kg using 
an analogical scale. Body mass index (BMI) was then calculated as weight (kilograms) 
divided by squared height (metres). 
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At the three-year follow-up evaluation, participants were questioned concerning 
educational level, marital and employment status, and income, before and three years 
after diagnosis. 
Clinical records were reviewed for cancer stage at diagnosis, which was classified 
according to the American Joint Committee on Cancer staging manual (29). 
To evaluate the presence of anxiety and depression at baseline, the Hospital Anxiety 
and Depression Scale (HADS) (30, 31) was applied. For each subscale, scores range 
from 0 to 21, and a score greater than or equal to 11 for each of them was considered a 
case of anxiety and/or depression, as applicable. 
The evaluation of participants’ health literacy was also performed three-years after the 
breast cancer diagnosis, using the Medical Term Recognition Test (METER), which was 
previously validated in the adult Portuguese population (32). This self-administered 
instrument consists in a list of 40 medical words and 30 made-up non-words that 
intuitively sound like real medical terms. The participants were asked to mark only the 
words they were sure to be actual words. Then, a score was calculated as the sum of all 
the correct words marked. Adequate health literacy was defined as scoring at least 35/40 
in words and 18/30 in non-words. 
To analyse proportions of participants meeting recommendations for cancer prevention, 
we adapted those established by the World Cancer Research Fund (8), assuming the 
following criteria: current non-smoking; alcohol consumption ≤1 unit per day; intake of at 
least five portions of fruit and/or vegetables per day; physically active (defined as 
practicing any sports or physical activity); normal weight (BMI <25kg/m2). 
 
Statistical analysis 
Prevalence estimates and respective 95% confidence intervals (95% CI) were estimated 
for each health behaviour and BMI categories. To quantify the association between 
breast cancer patients’ characteristics and changes in health behaviours and body mass 
index after diagnosis, adjusted odds ratios (AOR) and 95% CI were computed using 
unconditional logistic regression; this analysis was stratified according to the adherence 
to cancer prevention recommendations before diagnosis. 
Statistical analysis was conducted using STATA®, version 11.2 (StataCorp, College 
Station, TX, USA).  
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Results 
Overall, 50.7% of the women had less than 55 years of age at baseline, and 70.1% had 
less than 10 years of education. Just over half the breast cancer patients were employed 
and had income equal or lower than 500€, and nearly three-quarters of participants were 
married or living with a partner. A total of 55.6% of the women were diagnosed with less 
advanced cancers (stages 0/I). At baseline, 38.4% and 7.7% had anxiety and 
depression, respectively. At the three-year follow-up evaluation, nearly half of 
participants had inadequate health literacy (Table 1). 
Concerning the prevalence of health behaviours and BMI (Table 2), 12.8% of the 
participants were current smokers previously diagnosis and 9.1% reported this behaviour 
after three years. The percentage of current drinkers diminished from 46.7% before 
diagnosis to 43.5% after diagnosis, and the proportion of women who referred a 
consumption of more than one drink per day pre- and post-diagnosis was 15.2% and 
11.7%, respectively. Before diagnosis, nearly 70% of women had an intake of fruits 
and/or vegetables lower than five portions per day, while at the three-year follow-up 
evaluation this proportion was 65.6%. The great majority of participants did not do any 
physical activity before and after diagnosis (82.7% and 83.9%, respectively). The 
prevalence of overweight and obesity increased from 56.3% to 68.6%. 
Figure 1 depicts the changes in health behaviours, according to the participants’ levels 
of exposure before diagnosis. Among breast cancer patients who met the respective 
recommendations for cancer prevention prior to diagnosis, none started to smoke and 
only one woman increased her alcohol consumption to more than one unit per day (0.3%, 
95% CI: 0.0-1.7). Among those eating at least five portions of fruits and/or vegetable per 
day, only 6.1% (95% CI: 3.0-11.8) reduced their intake to values below the 
recommendations. More than a half of women that reported physical activity before 
diagnosis, had ceased this behaviour (54.1%, 95% CI: 42.8-64.9), and nearly one-third 
of women with normal weight had become overweight or obese (32.4%, 95% CI: 26.1-
39.5). Among breast cancer patients who did not meet the recommendations to each 
exposure before diagnosis, 29.1% quitted smoking after diagnosis (95% CI: 18.7-42.2) 
and 24.6% reduced alcohol consumption to values below the recommendations (95% 
CI: 15.7-36.4). A total of 9.9% of the participants become physically active (95% CI: 7.2-
13.5) and 7.8% increased their fruits and/or vegetables intake to at least five portions per 
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day (95% CI: 5.2-11.5). Considering overweight or obese women before diagnosis, 3.3% 
presented normal weight three years after diagnosis (95% CI: 1.6-6.6). 
With regards to the potential factors that may influence changes in health behaviours 
and BMI after a breast cancer diagnosis, women with older ages (AOR=4.71, 95% CI: 
1.17-18.99) and higher education levels (AOR=11.53, 95% CI: 2.20-60.53) were 
significantly more likely to cease physical activity in the period post-diagnosis (Table 3). 
Among breast cancer patients who were physically inactivate before diagnosis, older 
women had significantly lower odds for starting this behaviour in the period post-
diagnosis (AOR=0.32, 95% CI: 0.14-0.75). Compared with breast cancer patients with 
less advanced cancers, those with cancer stage II more frequently decreased their 
consumption of alcoholic beverages to less than one unit per day (AOR=4.36, 95% CI: 
1.02-18.68) (Table 4). 
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Discussion 
The present study has shown that, breast cancer patients often change their health 
behaviours and BMI after diagnosis, although these modifications differ by type of 
behaviour and adherence to cancer prevention recommendations before diagnosis. 
Globally, among patients who did not meet recommendations prior to diagnosis, there 
was a decrease in smoking and alcohol consumption and a slight increase in fruit and/or 
vegetables intake and physical activity. However, half of women that were physically 
active before breast cancer ceased this practice and one-third of those with normal 
weight were overweight or obese three years after diagnosis. 
With regards to smoking consumption, we observed that almost 30% of smokers before 
diagnosis quitted smoking after breast cancer, which is similar with results found in 
another study (25). Interestingly, when compared to the Portuguese women from general 
population, the prevalence of current smokers after breast cancer diagnosis was lower 
(33). Therefore, we can assume that cancer survivors may be more receptive to change 
this behaviour after diagnosis, since not smoking is commonly recognized as the most 
important behaviour for cancer prevention (34), which may be a result of the greater 
attention that mass media gives to tobacco than other risk factors (35), as well as the 
impact of tobacco control policies (36) and their public discussion (37), in the awareness 
of the harmful effects of smoking. 
Our results showed that, after diagnosis, almost one-quarter of breast cancer patients 
who are excessive drinkers before diagnosis decreased the consumption of alcoholic 
beverages, with 12% reporting consumptions higher than recommended three years 
after diagnosis. In prior studies, the prevalence of excessive alcohol consumption among 
breast cancer survivors ranged from 4.7% to 6.8% (38, 39). These differences may be 
due to different patterns of alcohol consumption across countries, as well as the use of 
distinct definitions and cut-off values among studies. Compared to other sample of 
women from general Portuguese population (40), after diagnosis, breast cancer patients 
were less likely to be current drinkers and excessive drinkers. These findings may reflect 
the effect of health promotion strategies; however, more noticeable improvements in 
alcohol consumption may be difficult to achieve, since moderate alcohol consumption is 
also advocated due to its protective effects on cardiovascular diseases and overall 
mortality (41). 
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Concerning fruits and vegetables intake, the prevalence of consumption lower than five 
portions per day after diagnosis observed in our study is similar to that observed in a 
previous study performed in the United States of America assessing breast cancer 
survivors (39); in reports from other countries, this prevalence is still high, varying from 
50.0% to 81.8%, despite the fact that, as observed in our study, the consumption of fruits 
and vegetables tended to increase after diagnosis (21, 25, 38, 39). Moreover, prior 
investigations did not observed differences in fruits and vegetables intake between 
cancer survivors and non-cancer controls (38, 42-44). Lack of information can be a 
barrier; for instance, a previous study conducted in United States of America showed 
that in few healthcare providers ask or advise cancer survivors about dietary habits (45). 
Three years after diagnosis, most participants have stopped their physical activity and, 
among those that were not physical active before diagnosis, few began this practice. 
Despite some studies reported higher levels of physical activity among cancer survivors 
(21, 25, 39), even when compared with general population (44), opposite results were 
also found (38, 46). The incongruent findings may be due to different instruments used 
to assess physical activity, distinct guidelines and characteristics of the samples. 
Additionally, compared with women from general Portuguese population (33), we found 
a higher prevalence of physical inactivity in breast cancer patients (70% versus 84%, 
respectively). In fact, lower levels of exercise in this population may be related with 
treatments’ side effects (47), including fatigue, depression or anxiety (48). 
The effect of cancer treatments, reduced physical functioning, increased fatigue, and 
weight gain are frequently associated with the higher levels of BMI previously observed 
in breast cancer survivors (49-51). Likewise, we also found an increase in BMI after 
diagnosis in those women that had normal weight pre-diagnosis, and three years post-
diagnosis only one-third had levels of BMI as recommended, which is much lower than 
the observed in general Portuguese women (33). Since the problem of excessive weight 
is a result of multiple interactions between several factors, including lifestyles, the 
implementation of actions to promote overall health education may also contribute to 
maintain a healthy weight among this population. 
In accordance to prior reports, we found that women with older age were more likely to 
report physical inactivity, particularly after treatments (52-54). Our work also revealed 
that more educated women were more likely to decrease their physical activity after 
diagnosis, which differs from the observed in previous studies (52, 54, 55). In addition, 
when compared with stages 0/I, women with more advanced stages more frequently 
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decreased their alcohol consumption after diagnosis to less than one unit per day. To 
the best of our knowledge, there are no data regarding the association between cancer 
stage and post-diagnosis alcohol consumption; however, in general, cancer survivors 
diagnosed with more advanced stages frequently make more positive changes in other 
health behaviours (e.g. smoking, diet), which may also be applied to alcohol consumption 
(53). 
The present study was based in a prospective cohort study and we were able to follow 
for three years a large proportion of the patients enrolled. However, it has some 
limitations that need to be addressed. We excluded patients not submitted to surgical 
treatment and those with stage IV, recurrence or diagnosis of other cancer, which may 
limit the generalization to patients with more advanced disease. Likewise, all patients 
were selected from the same institution, the Portuguese Institute of Oncology of Porto. 
However, this is the largest hospital providing care to oncological patients in the north of 
Portugal, receiving patients from a wide geographical area, which may reduce this 
limitation. 
Furthermore, information on health behaviours before breast cancer diagnosis was 
collected retrospectively, which may be hampered by recall bias. Since health 
behaviours were self-reported, desirability bias may also have occurred, which may 
contribute for an underestimation of smoking and alcohol consumption and 
overestimation of physical activity and fruit and vegetables intake. Furthermore, we were 
not able to measure the frequency, intensity and type of physical activity, and information 
regarding body weight before and after diagnosis was retrieved from different sources. 
METER was only applied at the three-year follow-up evaluation; although it may not 
reflect baseline levels of health literacy, since it may be improved by the higher contact 
with health systems after diagnosis, it may still allow the stratification of the sample 
according to broad categories of health literacy. 
Likewise, it was not possible to verify how health behaviours and BMI changed in a non-
cancer group from the general population, within this period of time. Nevertheless, due 
to the short period of follow-up, this fact may not have influenced our results. The 
possibility of observing other statistically significant associations between patients’ 
characteristics and changes in health behaviours and BMI may have been hampered by 
the smaller sample size, and consequent reduced statistical power, inherent to the 
stratification of the analysis according to adherence of cancer prevention 
recommendation. 
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Our findings have shown that there is room to implement interventions specifically 
developed to promote healthier behaviours in this population, in order to create an 
opportunity for cancer survivors to maximize outcomes in survivorship, prevent chronic 
conditions and improve prognosis. Since most of cancer patients previously reported a 
marginal interest in seeking surveillance and health promotion information, even in the 
post-treatment phase (58), healthcare providers, particularly oncologists and primary 
care physicians, have a key role to promote health education and positively influence 
changes in health behaviours. 
In conclusion, this study has shown that, although breast cancer patients performed 
some positive changes in their health behaviours, there is a large margin for 
improvement, which highlights the urgent demand for health promotion interventions in 
this context. 
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Table 1. Socio-demographic characteristics, cancer stage, anxiety, depression and 
health literacy of breast cancer patients. 
 N (%) 
n=428 
Age at baseline (years)  
<55 217 (50.7) 
≥55 211 (49.3) 
Education before diagnosis (years)  
4 178 (41.6) 
5-9 122 (28.5) 
>9 128 (29.9) 
Employment status before diagnosis  
Employed 224 (52.3) 
Unemployed, retired or housewife 204 (47.7) 
Income before diagnosis*  
≤500€  230 (54.9) 
>500€  189 (45.1) 
Marital status before diagnosis  
Married/cohabitation 313 (73.1) 
Other 115 (26.9) 
Cancer stage at baseline  
0/I 238 (55.6) 
II 134 (31.3) 
III 56 (13.1) 
Anxiety at baseline 164 (38.4) 
Depression at baseline† 33 (7.7) 
Inadequate health literacy three years after 
diagnosisǂ 197 (49.5) 
* N=419 due to one missing value and eight participants that did not know/answer. 
† N=427 due to missing values. 
ǂ N=398 due to missing values. 
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Table 2. Health behaviours and body mass index among breast cancer patients before 
and three years after diagnosis. 
 Before 
diagnosis 
N (%) 
3-years after 
diagnosis 
N (%) 
Smoking status   
Never 337 (78.7) 337 (78.7) 
Former smoker 36 (8.4) 52 (12.2) 
Current smoker 55 (12.8) 39 (9.1) 
Alcohol consumption   
Never 225 (52.6) 216 (50.5) 
Former drinker 3 (0.7) 26 (6.1) 
Current drinker 200 (46.7) 186 (43.5) 
Current drinker >1 unit/day 65 (15.2) 50 (11.7) 
Fruits and vegetables intake    
< 5 portions/day 294 (69.2) 279 (65.6) 
≥ 5 portions/day 131 (30.8) 146 (34.4) 
Physical activity   
No 354 (82.7) 359 (83.9) 
Yes 74 (17.3) 69 (16.1) 
Total number of unhealthy 
behaviours* 
  
≤1 133 (31.4) 163 (38.4) 
2 221 (52.1) 206 (48.6) 
≥3 70 (16.5) 55 (13.0) 
BMI (kg/m2)   
Normal weight  185 (43.6) 133 (31.4) 
Overweight 143 (33.7) 179 (42.2) 
Obesity 96 (22.6) 112 (26.4) 
BMI, body mass index. 
* Includes current smoking, alcohol consumption >1 unit per day, intake of <5 portions of fruit and/or vegetables per day 
and physical inactivity. 
Note: In each variable, the total may not add to 428 because only participants with information concerning both 
moments were included in this analysis. 
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Figure 1. Changes in health behaviours and body mass index after diagnosis among 
breast cancer patients who did and did not meet recommendations for cancer 
prevention before diagnosis. 
 Health behaviours and body mass index before diagnosis 
 
Meeting  
recommendations* 
Not meeting 
recommendations* 
 
 
 
* Recommendations include current non-smoking, alcohol consumption ≤1 unit per day, intake of ≥5 portions of fruits 
and/or vegetables per day, physical activity, and body mass index <25.0kg/m2.. 
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Table 3. Association between participants’ characteristics and adoption of unhealthy 
behaviours and overweight/obesity three years after diagnosis, among breast cancer 
patients who met recommendations before diagnosis. 
 Health behaviours and body mass index three-years after diagnosis 
(only among breast cancer patients who met recommendations before diagnosis*,†) 
 Fruits and vegetables intake 
<5 portions/day Physical inactivity Overweight/Obesity 
 
% (95% CI) 
AOR 
(95% CI)ǂ 
% (95% CI) 
AOR 
(95% CI)ǂ 
% (95% CI) 
AOR 
(95% CI)ǂ 
All 6.1 (3.0-11.8) ----- 54.1 (42.8-64.9) ----- 32.4 (26.1-39.5) ----- 
Age at baseline 
(years) 
      
<55 3.2 (0.2-11.5) 1 [reference] 50.0(35.5-64.5) 1 [reference] 36.6 (28.3-45.8) 1 [reference] 
≥55 8.8 (3.8-18.3) 4.14 (0.68-25.34) 59.4 (42.2-74.5) 4.71 (1.17-18.99) 26.0 (17.3-37.2) 0.56 (0.28-1.12) 
Education before 
diagnosis (years) 
      
4 5.5 (1.3-15.4) 1 [reference] 33.3 (16.1-56.4) 1 [reference] 35.1 (24.0-48.1) 1 [reference] 
5-9 5.9 (0.7-20.1) 1.39 (0.21-9.26) 50.0 (29.9-70.1) 5.00 (0.89-28.07) 34.5 (23.5-47.4) 0.69 (0.30-1.60) 
>9 7.1 (1.8-19.7) 2.19 (0.38-12.74) 66.7 (50.3-79.9) 11.53 (2.20-60.53) 28.6 (19.3-40.1) 0.57 (0.25-1.28) 
Employment status 
before diagnosis 
      
Employed 6.0 (1.9-14.8) 1 [reference] 57.1 (43.3-70.0) 1 [reference] 34.8 (26.7-43.9) 1 [reference] 
Unemployed, retired 
or housewife 
6.2 (2.0-15.4) 0.60 (0.11-3.31) 48.0 (30.0-66.5) 0.49 (0.11-2.07) 28.6 (19.3-40.1) 0.86 (0.39-1.88) 
Income before 
diagnosis 
      
≤500€  8.6 (3.7-17.8) 1 [reference] 39.1 (22.1-59.3) 1 [reference] 27.7 (19.2-38.2) 1 [reference] 
>500€  3.4 (0.3-12.4) 0.29 (0.04-1.89) 60.0 (46.2-72.4) 1.13 (0.25-5.14) 35.7 (26.9-45.6) 1.57 (0.76-3.23) 
Marital status before 
diagnosis 
      
Married/cohabitation 4.9 (1.8-11.2) 1 [reference] 53.8 (40.5-66.7) 1 [reference] 33.8 (26.5-42.0) 1 [reference] 
Other 10.3 (2.8-27.2) 1.79 (0.35-9.09) 54.5 (34.6-73.1) 1.16 (0.37-3.65) 28.3 (17.2-42.7) 0.82 (0.38-1.73) 
Cancer stage at 
baseline 
      
0/I 5.5 (1.7-13.7) 1 [reference] 54.5 (40.1-68.3) 1 [reference] 29.1 (21.4-38.2) 1 [reference] 
II 6.8 (1.7-18.9) 1.30 (0.27-6.34) 50.0 (30.7-69.3) 0.85 (0.28-2.59) 34.5 (23.3-47.8) 1.31 (0.64-2.67) 
III 7.1 (0.0-33.5) 2.20 (0.20-24.65) 62.5 (30.4-86.5) 1.38 (0.25-7.61) 45.0 (25.8-65.8) 1.92 (0.69-5.32) 
Anxiety at baseline       
No 4.9 (1.5-12.3) 1 [reference] 55.1 (41.3-68.2) 1 [reference] 28.0 (20.4-37.2) 1 [reference] 
Yes 8.2 (2.7-19.7) 1.55 (0.35-6.78) 52.0 (33.5-70.0) 0.81 (028-2.36) 37.7 (27.7-48.8) 1.64 (0.86-3.11) 
Depression at 
baseline 
      
No 5.1 (2.1-10.9) 1 [reference] 51.5 (39.7-63.2) 1 [reference] 32.4 (25.8-39.7) 1 [reference] 
Yes 15.4 (3.1-43.5) 2.31 (0.34-15.76) 75.0 (40.1-93.7) 2.01 (0.33-12.32) 33.3 (15.0-58.5) 1.05 (0.33-3.32) 
Health literacy three 
years after diagnosis 
      
Adequate 7.7 (2.9-17.2) 1 [reference] 62.0 (48.1-74.2) 1 [reference] 26.2 (18.6-35.5) 1 [reference] 
Inadequate 3.8 (0.3-13.5) 0.54 (0.08-3.82) 40.0 (21.8-61.4) 0.69 (0.18-2.71) 43.8 (33.0-55.2) 2.02 (0.95-4.30) 
AOR, adjusted odds ratio; CI, confidence interval. 
* Recommendations include current non-smoking, consumption of ≤1 alcoholic beverage per day, intake of ≥5 portions of fruits and/or 
vegetables per day, physical activity, and body mass index <25.0kg/m2. 
† Smoking status and alcohol consumption were not included because none participant started to smoke after diagnosis and only one 
woman increased her alcohol consumption to >1unit per day. 
ǂ Adjusted for age, education and cancer stage. 
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Table 4. Association between participants’ characteristics and adoption of healthy behaviours and normal weight three years after diagnosis, 
among breast cancer patients who did not meet recommendations before diagnosis. 
 
Health behaviours and body mass index three-years after diagnosis 
(only among breast cancer patients who did not met recommendations before diagnosis*) 
 
Current 
non-smoking 
Alcohol consumption 
≤1 drink/day 
Fruits and vegetables intake 
≥5 portions/day Physical activity Normal weight 
 % (95% CI) AOR (95% CI)† % (95% CI) AOR (95% CI)† % (95% CI) AOR (95% CI)† % (95% CI) AOR (95% CI)† % (95% CI) AOR (95% CI)† 
All 29.1 (18.7-42.2) ----- 24.6 (15.7-36.4) ----- 7.8 (5.2-11.5) ----- 9.9 (7.2-13.5) ----- 3.3 (1.6-6.6) ----- 
Age at baseline (years)           
<55 31.0 (19.0-46.1) 1 [reference] 18.2 (6.7-39.1) 1 [reference] 11.2 (7.0-17.3) 1 [reference] 14.9 (10.3-20.9) 1 [reference] 1.0 (0.0-5.8) 1 [reference] 
≥55 23.1 (7.5-50.9) 0.69 (0.15-3.20) 27.9 (16.6-42.8) ------- 4.2 (1.8-9.2) 0.44 (0.15-1.29) 5.0 (2.5-9.4) 0.32 (0.14-0.75) 5.2 (0.2-10.5) 4.48 (0.45-44.35) 
Education before diagnosis (years)           
4 20.0 (2.0-64.0) 1 [reference] 20.5 (10.5-35.8) 1 [reference] 4.9 (2.1-10.5) 1 [reference] 7.5 (4.2-12.8) 1 [reference] 5.1 (2.1-10.9) 1 [reference] 
5-9 33.3 (17.0-54.8) 2.12 (0.18-24.77) 46.7 (24.8-69.9) ------- 9.2 (4.5-17.3) 1.27 (0.38-4.28) 7.8 (3.8-14.9) 0.65 (0.24-1.77) ------- ------ 
>9 27.6 (14.5-45.9) 1.57 (0.14-18.01) 9.1 (0.0-39.9) 0.54 (0.05-6.24) 10.6 (5.5-19.1) 1.42 (0.44-4.58) 16.3 (10.0-25.3) 1.54 (0.65-3.68) 3.4 (0.3-12.4) 1.18 (0.20-6.92) 
Employment status before diagnosis           
Employed 27.5 (16.0-43.0) 1 [reference] 26.1 (12.3-46.8) 1 [reference] 9.0 (5.4-14.7) 1 [reference] 14.3 (9.8-20.3) 1 [reference] 1.9 (0.1-6.9) 1 [reference] 
Unemployed, retired or housewife 33.3 (15.0-58.5) 1.85 (0.42-8.11) 23.8 (13.3-38.7) 0.98 (0.22-4.40) 6.5 (3.3-12.0) 1.35 (0.47-3.84) 5.6 (2.9-10.1) 0.61 (0.25-1.54) 4.6 (1.9-9.8) 1.26 (0.19-8.25) 
Income before diagnosis           
≤500€  33.3 (16.1-56.4) 1 [reference] 20.0 (10.2-35.0) 1 [reference] 4.4 (2.0-8.9) 1 [reference] 6.8 (4.0-11.1) 1 [reference] 3.5 (1.3-8.1) 1 [reference] 
>500€  24.2 (12.6-41.3) 0.46 (0.09-2.32) 32.0 (17.1-51.7) 3.12 (0.74-13.11) 10.9 (6.5-17.6) 2.34 (0.77-7.07) 13.7 (8.8-20.4) 1.62 (0.68-3.87) 2.2 (0.1-8.1) 1.49 (0.19-11.70) 
Marital status before diagnosis           
Married/cohabitation 26.2 (15.2-41.2) 1 [reference] 22.0 (12.6-35.4) 1 [reference] 8.1 (5.1-12.7) 1 [reference] 8.8 (5.9-12.9) 1 [reference] 3.5 (1.4-7.6) 1 [reference] 
Other 38.5 (17.6-64.6) 1.62 (0.42-6.29) 33.3 (15.0-58.5) 1.16 (0.23-5.90) 7.1 (3.0-14.8) 1.03 (0.38-2.82) 12.9 (7.4-21.4) 1.73 (0.79-3.80) 3.0 (0.2-10.9) 0.64 (0.12-3.55) 
Cancer stage at baseline           
0/I 28.6 (15.1-47.2) 1 [reference] 17.6 (8.0-33.9) 1 [reference] 6.1 (3.2-11.1) 1 [reference] 8.8 (5.5-13.7) 1 [reference] 4.0 (1.5-9.3) 1 [reference] 
II 27.8 (12.2-51.2) 0.81 (0.20-3.21) 33.3 (18.5-52.3) 4.36 (1.02-18.68) 13.5 (7.7-22.3) 1.92 (0.77-4.77) 10.7 (6.1-17.9) 1.10 (0.49-2.46) 2.6 (0.2-9.4) 0.92 (0.17-5.05) 
III 33.3 (11.7-64.9) 1.10 (0.19-6.34) 25.0 (3.4-71.1) 2.92 (0.14-60.64) 2.4 (0.0-13.4) 0.32 (0.04-2.65) 12.5 (5.5-25.1) 1.35 (0.48-3.76) 2.8 (0.0-15.4) 1.01 (0.11-9.35) 
Anxiety at baseline           
No 29.0 (15.9-46.7) 1 [reference] 18.4 (8.9-33.7) 1 [reference] 5.6 (2.9-10.1) 1 [reference] 9.3 (6.1-14.1) 1 [reference] 3.9 (1.6-8.4) 1 [reference] 
Yes 29.2 (14.7-49.4) 0.94 (0.27-3.24) 33.3 (18.5-52.3) 3.80 (0.85-17.04) 11.4 (6.7-18.7) 2.10 (0.87-5.10) 10.8 (6.5-17.1) 1.21 (0.58-2.50) 2.4 (0.1-8.8) 0.61 (0.12-3.17) 
Depression at baseline           
No 29.4 (18.6-43.1) 1 [reference] 23.0 (14.1-35.0) 1 [reference] 7.7 (5.0-11.5) 1 [reference] 10.3 (7.5-14.1) 1 [reference] 3.2 (1.4-6.5) 1 [reference] 
Yes 25.0 (3.4-71.1) 0.76 (0.07-8.50) 50.0 (15.0-85.0) 3.57 (0.36-35.26) 10.0 (1.6-31.3) 1.21 (0.25-5.83) 4.0 (0.0-21.1) 0.42 (0.05-3.25) 5.9 (0.0-28.9) 2.23 (0.23-22.04) 
Health literacy three years after 
diagnosis 
          
Adequate 29.3 (17.5-44.6) 1 [reference] 25.9 (12.9-44.9) 1 [reference] 7.4 (3.9-13.2) 1 [reference] 11.9 (7.6-18.1) 1 [reference] 2.0 (0.1-7.6) 1 [reference] 
Inadequate 33.3 (13.6-61.2) 1.22 (0.21-7.13) 27.3 (14.9-44.4) 1.74 (0.36-8.39) 9.2 (5.3-15.1) 1.67 (0.62-4.54) 9.0 (5.6-14.3) 0.84 (0.37-1.90) 2.5 (0.5-7.3) 1.54 (0.19-12.23) 
AOR, adjusted odds ratio; CI, confidence interval. 
* Recommendations include current non-smoking, consumption of ≤1 alcoholic beverage per day, intake of ≥5 portions of fruits and/or vegetables per day, physical activity, and body mass index <25.0kg/m2. 
† Adjusted for age, education and cancer stage. 
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6. Conclusion 
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In conclusion, the present study have shown that, although breast cancer patients 
made some positive changes in health behaviours and BMI, women who met the 
recommendations for cancer prevention before diagnosis tended to maintain their 
smoking status, alcohol consumption and fruits and/or vegetables intake, and to 
cease physical activity and to increase BMI. Among the ones who did not met 
recommendations before diagnosis, only a few improved their behaviours and 
anthropometric characteristics. 
These findings highlight the importance of outlining specific follow-up plans for the 
monitoring of these patients after treatments, with a particular focus on health 
behaviours and BMI, in order to reduce their risk of other comorbidities and to 
achieve a better overall health status. 
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